• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗克尔曼沙阿医疗中心收治的 COVID-19 患者血脂谱变化:病例对照研究。

Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case-control study.

机构信息

Clinical Research Development Center, Imam Reza Hospital, 48464Kermanshah University of Medical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Department of Biochemistry, Faculty of Veterinary Medicine, Shiraz University, Shiraz, Iran.

出版信息

J Int Med Res. 2022 Feb;50(2):3000605221078699. doi: 10.1177/03000605221078699.

DOI:10.1177/03000605221078699
PMID:35196906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8883308/
Abstract

OBJECTIVE

To evaluate blood lipid profiles in patients with coronavirus disease 2019 (COVID-19), and to explore the association with disease severity.

METHODS

This case-control study included patients with COVID-19, referred to two medical centers in Kermanshah, Iran (between July 2020 and December 2020), and healthy controls. Lipid profiles were evaluated in patients who were grouped according to severe (intensive care unit [ICU]), or less severe (outpatient), forms of COVID-19, and in healthy controls, and were compared among the three groups.

RESULTS

A total of 132 participants were included, comprising ICU ( = 49), outpatient ( = 48) and control ( = 35) groups. Mean cholesterol levels were lower in the patient groups than in controls; high-density lipoprotein cholesterol (HDL-C) levels were higher in the ICU group versus outpatients, and low-density lipoprotein cholesterol (LDL-C) levels were lower in the ICU group versus outpatients. The frequency of diabetes and hypertension was higher in the ICU group than in the outpatient group. Furthermore, LDL-C level was associated with disease severity (odds ratio 0.966, 95% confidence interval 0.944, 0.989).

CONCLUSION

Lipid profiles differ between severe and less severe forms of COVID-19. LDL-C level may be a useful indicator of COVID-19 severity.

摘要

目的

评估 2019 年冠状病毒病(COVID-19)患者的血脂谱,并探讨其与疾病严重程度的关系。

方法

本病例对照研究纳入了 2020 年 7 月至 12 月期间在伊朗克尔曼沙赫的两家医疗机构就诊的 COVID-19 患者和健康对照者。根据 COVID-19 的严重程度(重症监护病房[ICU])或较轻程度(门诊)将患者分组,评估血脂谱,并在三组之间进行比较。

结果

共纳入 132 名参与者,包括 ICU 组( = 49)、门诊组( = 48)和对照组( = 35)。与对照组相比,患者组的胆固醇水平较低;与门诊组相比,ICU 组的高密度脂蛋白胆固醇(HDL-C)水平较高,而 LDL-C 水平较低。与门诊组相比,ICU 组的糖尿病和高血压患病率更高。此外,LDL-C 水平与疾病严重程度相关(比值比 0.966,95%置信区间 0.944,0.989)。

结论

严重和较轻形式的 COVID-19 患者的血脂谱存在差异。LDL-C 水平可能是 COVID-19 严重程度的一个有用指标。

相似文献

1
Lipid profile changes in patients with COVID-19 referred to medical centers in Kermanshah, Iran; a case-control study.伊朗克尔曼沙阿医疗中心收治的 COVID-19 患者血脂谱变化:病例对照研究。
J Int Med Res. 2022 Feb;50(2):3000605221078699. doi: 10.1177/03000605221078699.
2
Lipid profile as an indicator of COVID-19 severity: A systematic review and meta-analysis.脂质谱作为 COVID-19 严重程度的指标:系统评价和荟萃分析。
Clin Nutr ESPEN. 2021 Oct;45:91-101. doi: 10.1016/j.clnesp.2021.07.023. Epub 2021 Jul 31.
3
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study.低高密度脂蛋白水平与 COVID-19 患者的严重程度相关:一项观察性研究。
Lipids Health Dis. 2020 Sep 7;19(1):204. doi: 10.1186/s12944-020-01382-9.
4
The clinical value of high-density lipoprotein in the evaluation of new coronavirus pneumonia.高密度脂蛋白在新型冠状病毒肺炎评估中的临床价值。
Adv Clin Exp Med. 2021 Feb;30(2):153-156. doi: 10.17219/acem/130606.
5
Association between lipid profile and clinical outcomes in COVID-19 patients.新冠肺炎患者血脂谱与临床结局的相关性。
Sci Rep. 2024 May 27;14(1):12139. doi: 10.1038/s41598-024-62899-y.
6
Hypolipidemia is associated with the severity of COVID-19.血脂异常与 COVID-19 的严重程度有关。
J Clin Lipidol. 2020 May-Jun;14(3):297-304. doi: 10.1016/j.jacl.2020.04.008. Epub 2020 Apr 30.
7
Is there any association between plasma lipid profile and severity of COVID-19?血浆脂质谱与 COVID-19 的严重程度之间是否存在关联?
Clin Nutr ESPEN. 2022 Jun;49:191-196. doi: 10.1016/j.clnesp.2022.04.026. Epub 2022 Apr 28.
8
Relationship Between Blood Lipid Levels and Mortality in Hospitalized COVID-19 Patients.住院 COVID-19 患者的血脂水平与死亡率的关系。
Angiology. 2022 Sep;73(8):724-733. doi: 10.1177/00033197211072346. Epub 2022 Feb 6.
9
Low HDL and high triglycerides predict COVID-19 severity.低 HDL 胆固醇和高甘油三酯与 COVID-19 严重程度相关。
Sci Rep. 2021 Mar 30;11(1):7217. doi: 10.1038/s41598-021-86747-5.
10
ABO Blood Type and Metabolic Markers in COVID-19 Susceptibility and Severity: A Cross-Sectional Study.ABO 血型与代谢标志物在 COVID-19 易感性和严重程度中的作用:一项横断面研究。
Metab Syndr Relat Disord. 2023 Aug;21(6):335-344. doi: 10.1089/met.2023.0022. Epub 2023 Jun 23.

引用本文的文献

1
Effect of COVID-19 on hematological parameters and subsequent risk of anemia and bleeding in middle-aged and elderly patients with type 2 diabetes.2019冠状病毒病对中老年2型糖尿病患者血液学参数及后续贫血和出血风险的影响
J Family Med Prim Care. 2025 Jul;14(7):2974-2979. doi: 10.4103/jfmpc.jfmpc_5_25. Epub 2025 Jul 21.
2
G Protein Subunit Beta 3 (GNB3) Variant Is Associated with Biochemical Changes in Brazilian Patients with Hypertension.G 蛋白亚基β 3(GNB3)变体与巴西高血压患者生化变化相关。
Arq Bras Cardiol. 2023 Dec;120(12):e20230396. doi: 10.36660/abc.20230396.
3
Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.SARS-CoV-2 感染中的混合性炎症风暴:Covid-19 时代的叙述性综述和新术语。
Immun Inflamm Dis. 2023 Apr;11(4):e838. doi: 10.1002/iid3.838.
4
Plasma lipid profile: a predictive marker of disease severity among COVID-19 patients-an opportunity for low-income countries.血浆脂质谱:COVID-19患者疾病严重程度的预测标志物——低收入国家的一个机遇。
Drugs Ther Perspect. 2022;38(6):286-291. doi: 10.1007/s40267-022-00916-8. Epub 2022 Jun 27.

本文引用的文献

1
COVID-19 induces proatherogenic alterations in moderate to severe non-comorbid patients: A single-center observational study.COVID-19 可诱导中重度非合并症患者产生促动脉粥样硬化改变:一项单中心观察性研究。
Blood Cells Mol Dis. 2021 Dec;92:102604. doi: 10.1016/j.bcmd.2021.102604. Epub 2021 Sep 9.
2
Statins use and COVID-19 outcomes in hospitalized patients.他汀类药物的使用与住院患者的 COVID-19 结局。
PLoS One. 2021 Sep 10;16(9):e0256899. doi: 10.1371/journal.pone.0256899. eCollection 2021.
3
Lack of significant association between dyslipidemia and COVID-19 mortality.血脂异常与新冠病毒疾病死亡率之间缺乏显著关联。
J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.001. Epub 2021 Mar 5.
4
Lipid metabolism changes in patients with severe COVID-19.严重 COVID-19 患者的脂代谢变化。
Clin Chim Acta. 2021 Jun;517:66-73. doi: 10.1016/j.cca.2021.02.011. Epub 2021 Feb 24.
5
An investigation of risk factors of in-hospital death due to COVID-19: a case-control study in Rasht, Iran.伊朗拉什特 COVID-19 院内死亡危险因素的调查:病例对照研究。
Ir J Med Sci. 2021 Nov;190(4):1321-1333. doi: 10.1007/s11845-020-02455-5. Epub 2021 Jan 15.
6
The Potential Role of Dyslipidemia in COVID-19 Severity: an Umbrella Review of Systematic Reviews.血脂异常在新冠病毒疾病严重程度中的潜在作用:系统评价的伞状综述
J Lipid Atheroscler. 2020 Sep;9(3):435-448. doi: 10.12997/jla.2020.9.3.435. Epub 2020 Sep 21.
7
Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action.他汀类药物在新冠病毒肺炎患者中的保护作用:药代动力学特征而非作用强度的重要性。
Intern Emerg Med. 2020 Nov;15(8):1573-1576. doi: 10.1007/s11739-020-02504-y. Epub 2020 Oct 3.
8
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study.低高密度脂蛋白水平与 COVID-19 患者的严重程度相关:一项观察性研究。
Lipids Health Dis. 2020 Sep 7;19(1):204. doi: 10.1186/s12944-020-01382-9.
9
COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm.COVID-19 激活的 SREBP2 扰乱胆固醇生物合成并导致细胞因子风暴。
Signal Transduct Target Ther. 2020 Sep 3;5(1):186. doi: 10.1038/s41392-020-00292-7.
10
Diabetes and COVID-19: A systematic review on the current evidences.糖尿病与 COVID-19:当前证据的系统综述。
Diabetes Res Clin Pract. 2020 Aug;166:108347. doi: 10.1016/j.diabres.2020.108347. Epub 2020 Jul 22.